Evaluation for NCI Surgery Branch Clinical Research Protocols
Recruiting
7,000 enrolled
A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid Tumors
Phase 1 Recruiting
124 enrolled
Psilocybin-Assisted Psychotherapy in Cancer Patients With Adjustment Disorder
Phase 2 Recruiting
87 enrolled
MK-3475-G21
Phase 1/2 Recruiting
20 enrolled
IDOV-Immune for Advanced Solid Tumors
Phase 1 Recruiting
78 enrolled
Project: Every Child for Younger Patients With Cancer
Recruiting
75,000 enrolled
ARTACUS
Phase 1/2 Recruiting
90 enrolled
The Florida ASCENT Study
Phase NA Recruiting
100 enrolled
ACTengine
Phase 1/2 Recruiting
375 enrolled
TTX-080 HLA-G Antagonist in Subjects With Advanced Cancers
Phase 1 Recruiting
240 enrolled
SELECT-CAR-NK
Phase 1/2 Recruiting
85 enrolled
EBNK-ST-001
Phase 1/2 Recruiting
83 enrolled
A Phase 1 Study of JMT108 in Participants With Advanced Solid Tumors
Phase 1 Recruiting
270 enrolled
ELEPHAS-05
Recruiting
2,000 enrolled
ELEPHAS-02
Recruiting
416 enrolled
ON-5001
Phase 1 Recruiting
168 enrolled
A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer
Phase 1 Recruiting
56 enrolled
Study of GV20-0251 in Participants With Solid Tumor Malignancies
Phase 1/2 Recruiting
350 enrolled
DETERMINE
Phase 2/3 Recruiting
30 enrolled
Cytotoxic T Lymphocytes in Treating Patients With Malignancies With BK and/or JC Virus
Phase 2 Recruiting
100 enrolled
NST-628
Phase 1 Recruiting
230 enrolled
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
Recruiting
15,000 enrolled
AGADIR
Phase 2 Recruiting
247 enrolled
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Phase 1 Recruiting
45 enrolled
Observational Study of Iris Tumors
Recruiting
100 enrolled
A Multilevel Approach to Connecting Underrepresented Populations to Clinical Trials
Recruiting
350 enrolled
Safety of SBRT With Anti-PD1 and Anti-IL-8 for the Treatment of Multiple Metastases in Advanced Solid Tumors and Melanoma
Phase 1 Recruiting
50 enrolled
DP-PAN-CANCER
Phase NA Recruiting
450 enrolled
START-001
Phase 1/2 Recruiting
365 enrolled
A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors
Phase 1/2 Recruiting
240 enrolled
Adaptive Symptom Self-Management Immunotherapy Study
Phase NA Recruiting
400 enrolled
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
Phase NA Recruiting
2,996 enrolled
PRIME
Phase 3 Recruiting
1,204 enrolled
A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents
Phase 1/2 Recruiting
168 enrolled
A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer
Phase 1/2 Recruiting
53 enrolled
MelMarT-II
Phase NA Recruiting
2,998 enrolled
Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067
Phase 1/2 Recruiting
316 enrolled
AI-MEL
Recruiting
3,000 enrolled
CER
Recruiting
15,000 enrolled
NТО-RAS
Phase 2 Recruiting
20 enrolled
ONCOPRO
Phase NA Recruiting
410 enrolled